Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT00109356
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
* Tumor specimen available for evaluation (please provide 10 unstained slides)
* Relapse after receiving primary treatment and at least one salvage therapy
* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
* Laboratory test measurements
* Females of childbearing potential must have a negative pregnancy test result within 3 days prior to the first dose and must agree to use an effective contraceptive method during the course of the study and for 6 months following the last dose of study drug.
* Older than 18 years of age
* Available for periodic blood sampling
Exclusion Criteria:
* Certain cardiac problems
* Previous donor stem cell transplant
* Known HIV, Hepatitis B, Hepatitis C infection
* Previous chemotherapy, radiation or other investigational drug treatments within 4 weeks of first planned dose of study drug
* Major surgery within four weeks of first planned dose of study drug
* Any active viral, bacterial, or fungal infection within four weeks of first planned dose of study drug
* Pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00109356
Study Brief:
Protocol Section:
NCT00109356